Precipio (NASDAQ:PRPO) Releases Earnings Results

Precipio (NASDAQ:PRPO) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.23) earnings per share for the quarter, Zacks reports. Precipio had a negative return on equity of 34.01% and a negative net margin of 17.23%.

Precipio Stock Performance

Shares of Precipio stock opened at $6.18 on Friday. The company has a quick ratio of 0.60, a current ratio of 0.73 and a debt-to-equity ratio of 0.02. The stock’s fifty day moving average is $7.12 and its two-hundred day moving average is $6.49. Precipio has a 52 week low of $4.31 and a 52 week high of $10.74. The company has a market capitalization of $9.16 million, a PE ratio of -3.38 and a beta of 1.37.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.